CV Sciences (CVSI) Gross Profit (QoQ) (2013 - 2026)
CV Sciences (CVSI) Gross Profit (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.55 Bn | 87.69 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.99 Bn | 32.25 Bn | 1.97 Bn |
| 3 | Zoetis | 32.64 Bn | 30.70 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.51 Bn | 23.45 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.29 Bn | 18.49 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.48 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | CV Sciences | 4.11 Mn | 3.80 Mn | 1.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.52% |
| Dec 31, 2025 | 5.83% |
| Sep 30, 2025 | -14.37% |
| Jun 30, 2025 | 11.22% |
| Mar 31, 2025 | -1.13% |
| Dec 31, 2024 | -5.68% |
| Sep 30, 2024 | -4.41% |
| Jun 30, 2024 | 0.38% |
| Mar 31, 2024 | 6.37% |
| Dec 31, 2023 | -5.48% |
| Sep 30, 2023 | 7.28% |
| Jun 30, 2023 | -3.59% |
| Mar 31, 2023 | 14.08% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 22.99% |
| Jun 30, 2022 | 9.86% |
| Mar 31, 2022 | -28.20% |
| Dec 31, 2021 | -31.72% |
| Sep 30, 2021 | 2.97% |
| Jun 30, 2021 | -2.88% |